European Archives - Page 997 of 1369 - European Medical Journal

A proactive approach to patient centricity

The increasing focus on patient centricity in recent years has ensured pharmaceutical companies are far more in sync with the issues that patients’ face on a day-to-day basis than ever before; however, translating these insights into treatment improvements remains a challenge.

An entrepreneurial approach to R&D

Decline in R&D productivity levels is rapidly becoming one of the biggest challenges for the pharmaceutical industry, but what can it do?

Amgen’s Victoria Elegant on driving innovation through diversity and inclusion

Victoria Elegant, Vice President and Region Head of Medical, Amgen, shares insights on the importance of diversity in delivering innovation, pharma in the JAPAC region and what medical affairs teams across the globe can learn from China.

Lead us on, medical affairs

Perfectly positioned to bridge the gap between R&D and commercial, MA must seize their strategic position within the industry to guide the future of the function.

Sexual Dysfunction: Quality of Life in Men with Prostate Cancer

SEXUAL DYSFUNCTION was one of the two major differences in quality of life (QoL) between men treated for advanced prostate cancer…

The Double Life of p53, the Guardian of the Genome

WIDELY understood as a suppressor of cancer development, earning it the nickname ‘the guardian of the genome’, the protein p53 may, in fact, also promote…

Metabolic Brain Age: Sex Differences Identified

OLDER women commonly outperform men in their age group in tests of reasoning, memory, and problem-solving, but the reason for this is currently unknown…

Low Coprococcus and Dialister Levels Linked with Depression

IS THERE a link between the gut and mental health? More specifically, is depression linked to gut bacteria? Scientists from Belgium set out to add another…

EMJ Dermatology 6 [Suppl 3] 2019

Prof Bieber opened the symposium by explaining that there has been a revolution in the management of patients with moderate-to-severe atopic dermatitis…

Translating Evidence to Practice: From Clinical Research to Real-World Experience

The goal of this programme is to support dermatologists to improve the management of patients with moderate-to-severe AD and bring together clinicians…